#LCSM Chat Topic 4-Mar-2021: Liquid Bx—It pays to be vein
Cancer diagnosis for solid tumors has traditionally relied on biopsied tumor tissue. For patients already diagnosed with lung cancer, blood-based liquid biopsies are increasingly being used to look for bits of tumor proteins or DNA that can help identify suitable treatment options. The US FDA has even approved two liquid biopsies that can detect actionable mutations in lung cancer. However, there are several liquid biopsies technologies, and researchers are exploring whether those could be used to answer other questions in the cancer space, such as: Early detection: Is cancer present? If so,… Read More
#LCSM Chat Topic 4-Feb-2021: “#WCLC20 from the comfort of your own home”
Well, we finally moved on to 2021, only to be thrust seemingly backward to #WCLC20! The incredible content from #WCLC20 was certainly worth the wait. Although we didn’t get to experience the meeting live together in Singapore, a new virtual platform brought it all to us in the comfort of our own homes. Several topics discussed at #WCLC20 stood out and deserve a deeper dive within the #LCSM community. There was a great deal of buzz about the TALENT study from Taiwan which looked at lung cancer screening in never or light… Read More
#LCSM Chat Topic 11/05/2020: Celebrating Safely During #COVID-19 Pandemic
The #LCSM Chat on November 5, 2020, at 8 pm Eastern (5 pm Pacific) is open to all members of the cancer community. As the leaves turns, daylight hours lessen, and the weather becomes cooler, we spend more time indoors. Our thoughts turn to holidays, a time when many expect to reunite with family and loved ones, and to celebrate with shared meals and warm embraces. However, as cases of COVID-19 are once again surging in almost every state, these activities present a serious risk for virus transmission. COVID-19 is an even… Read More
You must be logged in to post a comment.